NCT07436156 SUMMIT RISE Study of Acute Ischemic Stroke Patients
| NCT ID | NCT07436156 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Route 92 Medical, Inc. |
| Condition | Acute Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-02-12 |
| Primary Completion | 2029-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 500 participants in total. It began in 2026-02-12 with a primary completion date of 2029-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Eligibility Criteria
Inclusion Criteria: * Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System * Informed consent completed and documented within 72 hours following thrombectomy procedure * Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well * Age ≥ 18 years Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07436156 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07436156 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07436156 currently recruiting?
Yes, NCT07436156 is actively recruiting participants. Contact the research team at reneek@r92m.com for enrollment information.
Where is the NCT07436156 trial being conducted?
This trial is being conducted at West Jordan, United States.
Who is sponsoring the NCT07436156 clinical trial?
NCT07436156 is sponsored by Route 92 Medical, Inc.. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.